publication venue for
- Patterns and predictors of cholinesterase inhibitor use in dementia with Lewy bodies. 2025
- Barriers to seeking care for memory problems: A vignette study. 2022
- Impact of non-binding FDA guidances on primary endpoint selection in Alzheimer's disease trials. 2022
- Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies. 2022